Category

RARE DISEASES

Home > Therapeutic Areas > RARE DISEASES (Page 2)

de Andrés-Nogales F, Calleja- Hernández MA, Delgado- Sánchez O, Gorgas- Torner MQ, Domínguez-Hernández R, Casado -Gómez MA, Arce- Delgado R; Grupo de Trabajo FinMHU-MCDA

 

Análisis de decisión multicriterio multidecisor en enfermedades raras: criterios de financiación de medicamentos huérfanos en España (Estudio FinMHU-MCDA)
65 Congreso Nacional de la Sociedad Española de Farmacia Hospitalaria (SEFH). Virtual 20-22 oct 2020

Santamaria R, De Juan-Ribera J, Martinez-Sanchez F, Pendon-Ruiz De Mier V, Gil-Garcia C, Lopez-Ruiz MJ, Casado A, Ordovas M, Espinosa M, Del Pino MD

 

Burden of disease in patients with Fabry disease: Economic burden of health care and non-health care resources consumption
56th Congress of European Renal Association-European Dyalisis and Transplant Association (ERA-EDTA). Budapest (Hungary). 13-16 jun 2019

POSTER

Santamaria R, De Juan-Ribera J, Martinez-Sanchez F, Pendon-Ruiz De Mier V, Gil-Garcia C, Lopez-Ruiz MJ, Casado A, Ordovas M, Espinosa M, Del Pino MD

 

Burden of disease in patients with fabry disease: Health related quality of life and associated factors
56th Congress of European Renal Association-European Dyalisis and Transplant Association (ERA-EDTA). Budapest (Hungary). 13-16 jun 2019

POSTER

Orofino J, Soto J, Casado MA, Oyagüez I

 

 

 

Global spending on orphan drugs in the main European markets (France, Germany, United Kingdom, Italy and Spain) during 2007
Appl Health Econ Health Policy. 2010;8(5):301-15